Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 55: 1361-1371, 2009. First published April 30, 2009; 10.1373/clinchem.2008.118661
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.118661v1
55/7/1361    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel, J. J.
Right arrow Articles by Lackner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, J. J.
Right arrow Articles by Lackner, K. J.
(Clinical Chemistry. 2009;55:1361-1371.)
© 2009 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Identification and Prevention of Genotyping Errors Caused by G-Quadruplex– and i-Motif–Like Sequences

Jürgen J. Wenzel1,1, Heidi Rossmann1,a,1, Christian Fottner2, Stefan Neuwirth3, Carolin Neukirch1, Peter Lohse4, Julia K. Bickmann1, Timo Minnemann2, Thomas J. Musholt5, Brigitte Schneider-Rätzke6, Matthias M. Weber2 and Karl J. Lackner1

1 Departments of Clinical Chemistry and Laboratory Medicine; and2 Medicine I, Johannes Gutenberg University Mainz, Mainz, Germany;3 Bundeskriminalamt, Wiesbaden, Germany;4 Institute of Clinical Chemistry – Großhadern, Ludwig-Maximilians University Munich, Munich, Germany;5 Endocrine Surgery; and6 Institute for Human Genetics, Johannes Gutenberg University Mainz, Mainz, Germany.

aAddress correspondence to this author at: Johannes Gutenberg University Mainz, Department of Clinical Chemistry and Laboratory Medicine, Langenbeckstr. 1, 55131 Mainz, Germany. Fax +49-6131-17-6627; e-mail rossmann{at}zentrallabor.klinik.uni-mainz.de.

Background: Reliable PCR amplification of DNA fragments is the prerequisite for most genetic assays. We investigated the impact of G-quadruplex– or i-motif–like sequences on the reliability of PCR-based genetic analyses.

Methods: We found the sequence context of a common intronic polymorphism in the MEN1 gene (multiple endocrine neoplasia I) to be the cause of systematic genotyping errors by inducing preferential amplification of one allelic variant [allele dropout (ADO)]. Bioinformatic analyses and pyrosequencing-based allele quantification enabled the identification of the underlying DNA structures.

Results: We showed that G-quadruplex– or i-motif–like sequences can reproducibly cause ADO. In these cases, amplification efficiency strongly depends on the PCR enzyme and buffer conditions, the magnesium concentration in particular. In a randomly chosen subset of candidate single-nucleotide polymorphisms (SNPs) defined by properties deduced from 2 originally identified ADO cases, we confirmed preferential PCR amplification in up to 50% of the SNPs. We subsequently identified G-quadruplex and i-motifs harboring a SNP that alters the typical motif as the cause of this phenomenon, and a genomewide search based on the respective motifs predicted 0.5% of all SNPs listed by dbSNP and Online Mendelian Inheritance in Man to be potentially affected.

Conclusions: Undetected, the described phenomenon produces systematic errors in genetic analyses that may lead to misdiagnoses in clinical settings. PCR products should be checked for G-quadruplex and i-motifs to avoid the formation of ADO-causing secondary structures. Truly affected assays can then be identified by a simple experimental procedure, which simultaneously provides the solution to the problem. .







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Association for Clinical Chemistry.